Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 8/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18961944 | 0.96 | PRKDC (0.34) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21735958 | 0.92 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL18961971 | 0.92 | NPC1 (0.30) | — | |
| SCHEMBL18962018 | 0.92 | ALOX5 (0.33) | PRKDCPIK3CDPIK3CBALOX5 | |
| SCHEMBL18962024 | 0.88 | ALOX5 (0.33) | PRKDCPIK3CDPIK3CBALOX5 | |
| SCHEMBL18962067 | 0.88 | CREBBP (0.32) | — | |
| SCHEMBL23026922 | 0.88 | PRKDC (0.33) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL18961973 | 0.87 | MAPT (0.36) | KDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL18961909 | 0.86 | PRKDC (0.32) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL18962021 | 0.86 | PRKDC (0.36) | PRKDCPIK3CDPIK3CBBRD4PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011608-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-03 | — | — | US | disclosed |
| US-10011608-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-03 | — | — | US | disclosed |
| US-20170166581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170166581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011608-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | PIEZO1, OR51E2, OCIAD1 | PRKDC 4031/4885PIK3CD 4095/4885PIK3CB 4416/4885 |
| US-20170166581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OCIAD1 | PRKDC 4031/4885PIK3CD 4095/4885PIK3CB 4416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.